Supplementary figures.docx (753.69 kB)
Download file

Supplementary figures: Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer.docx

Download (753.69 kB)
posted on 31.08.2021, 10:18 by Stacey M. Stein, Jeremy Snider, Siraj M. Ali, Rebecca A. Miksad, Brian M. Alexander, Emily Castellanos, Alexa B. Schrock, Russell Madison, Akshay Swaminathan, Jeffrey M. Venstrom, Margaret McCusker

Supplemental figure 1: Cohort attrition

Supplemental Figure 2: TTD and OS by IHC status for HER2 ISH+ patients with IHC results (n = 38)

Supplemental figure 3: TTD and OS by KRAS status